药物联合团体认知行为治疗强迫症的临床效果

Clinical Effect of Drug Combination with Group Cognitive Behavioral Therapy on Obsessive-compulsive Disorder

目的:对比观察单纯药物治疗及药物联合团体认知疗法对强迫症的临床效果。方法:选取笔者所在医院2017年1月-2018年5月57例强迫症患者,将其按奇偶数分组法分为两组,即单纯药物治疗组(药物组)28例,药物联合团体认知行为治疗组(联合组)29例。在进行8周治疗后,用耶布朗强迫症评分量表及生活质量评分量表对治疗前后的症状及生活质量进行评估。结果:联合组治疗后患者强迫症症状较治疗前及药物组明显低(P<0.05);与药物组治疗后及联合组治疗前相比,联合组治疗后的生活质量明显高(P<0.05)。结论:药物联合团体认知治疗能有效改善强迫症患者强迫症症状,提高生活质量。

Objective:To compare the clinical effects of drug therapy alone and drug combination group cognitive therapy on obsessive-compulsive disorder(OCD).Method:From January 2017 to May 2018,57 patients with obsessive-compulsive disorder in our hospital were divided into two groups according to odd and even number,28 patients in the simple drug treatment group(the drug group)and 29 patients in the drug combined group cognitive behavior treatment group(the combined group).After 8 weeks of treatment,the symptoms and quality of life were evaluated with the Yebron obsessive-compulsive disorder scale and the quality of life scale.Result:After treatment,the symptoms of obsessive-compulsive disorder in the combined group were significantly lower than those before treatment and in the drug group(P<0.05),and the quality of life in the combined group was significantly higher than that before treatment and that in the drug group(P<0.05).Conclusion:Drugs combined with group cognitive therapy can effectively improve the symptoms and quality of life of obsessive-compulsive disorder patients.